|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Kylie O'Brien , Philip BlairPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2021 Weight: 1.114kg ISBN: 9783030785581ISBN 10: 3030785580 Pages: 576 Publication Date: 28 October 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsIntroduction Endocannabinoid system: will cover what the endocannabinoid system is, the concept of endocannabinoid deficiency Overview of cannabis: will cover what is cannabis, historical use in mental health, active constituents with a focus on CBD (but also including THC, terpenes) Pharmacokinetics and Safety: including potential toxicity, recreational cannabis vs medicinal uses, drug-herb interactions Stress and Anxiety: will cover how CBD can reduce anxiety (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study (1-2). Depression: will cover how CBD can reduce depression (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. Sleep disorders: will cover how CBD can be used to treat insomnia and sleep apnoea (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study. PTSD: will cover how CBD can be used to treat PTSD (mechanisms of action), and the scientific evidence for efficacy. It will also include guidance on dosing, and a case study Co-morbid chronic pain and mental health: will cover how CBD can be used to treat chronic pain and co-morbid mental health issues- sleep and depression, and the scientific evidence for efficacy. It will also include guidance on dosing, and 2 case studies. Dementia: will cover the evidence for its efficacy in treating dementia including Alzheimer’s Disease. ADHD, Autism End of life and existential matters- the role of cannabis including CBD Conclusion: will cover a holistic approach to treatment of mental health that includes cannabis then conclude the book.ReviewsAuthor InformationProfessor Kylie O’Brien PhDKylie O’Brien PhD Adjunct Professor Torrens University Director of Research & Education International College of Cannabinoid Medicine Email: kylie@iccm.co Phone: +61 412 077689 Dr Philip Blair, MDDr. Philip Blair, MD, Colonel (US Army Ret) CEO of AbleDoc, Inc, International Medical Consultant Chief Medical Officer, International College of Cannabinoid Medicine Chief Medical Officer, Releaf Clinics, Australia Chief Science Officer for Harvest 360 Castle Rock, Washington email: abledoc@mac.com Tab Content 6Author Website:Countries AvailableAll regions |